Go to main content

Solvable Problems in Diabetes at EASD 2023

diaTribe Solvable Problems at EASD 2023 Panelists

Join us in Hamburg for a festive gathering and enlightening
panel discussion, chaired and moderated by Professor Melanie Davies, CBE

The New Era for Optimizing Care in Type 2 Diabetes

Wednesday, October 4, 2023 at 7:00pm CEST​

Empire Riverside Hotel, Hamburg
Bernhard-Nocht-Straße 97
20359 Hamburg, Germany


Recent advancements in T2D therapies and technology that allow for more effective glucose management, unprecedented weight loss, and new opportunities for reducing the risk of diabetes complications are dramatically changing the potential for optimizing care in T2D. Join friends and colleagues for a deep discussion by a panel of leading women in the field, chaired by Professor Melanie Davies, CBE (University of Leicester, UK), about what lies ahead and the challenges that remain. 

Topics will include the latest developments in therapies for producing disease-modifying weight loss without bariatric surgery, advancements in long-acting insulins and dual and triple agonists for better glucose management and the prevention of complications, the role of technology and Time in Range for managing T2D, issues of access and social determinants of health in addressing the larger T2D epidemic, and much more.

Our group of international, all women panelists (bios below) include Dr. Roberta Lamptey (Korle Bu Teaching Hospital, Ghana), Dr. Claire Meek (University of Cambridge, UK), Dr. Nisa Maruthur (Johns Hopkins University, USA), Dr. Athena Philis-Tsimikas (Scripps Whittier Diabetes Institute, USA), and Dr. Tsvetalina Tankova (Medical University, Sofia, Bulgaria). The panel discussion will be preceded by a cocktail reception where you’ll have the opportunity to network and connect with colleagues and friends.

Solvable Problems in Diabetes is a ticketed event to benefit the charitable work of The diaTribe Foundation and space is limited.

Deeply discounted tickets (50% off) for clinicians, researches, and non-profit advocates are available by entering the discount code ADVOCATE at registration. You must provide credentials and affiliation during registration to qualify for this discount. 

A limited number for complimentary tickets are available for event sponsors (below), contact Rachel Allen for more information about those tickets,  sponsorship opportunities, and any other ticketing questions you may have.



Prof Melanie Davies, CBEMelanie Davies, CBE, MB ChB, MD, FRCP, FRCGP, FMedSci

Professor of Diabetes Medicine, University of Leicester, UK

Melanie Davies is Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust.  She is the Co-Director of the Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust.  Professor Davies’ research interests include the causes, screening, prevention, self-management and treatment of type 2 diabetes mellitus.  She is a National Institute for Health Research Senior Investigator Emeritus and Director of the NIHR Leicester Biomedical Research Centre and co-chair of EASD/ADA’s Consensus Report on T2D Management. Professor Davies has published over 800 original articles and has over £100M of grant funding. She was awarded the CBE (Commander of the Most Excellent Order of the British Empire) in the 2016 New Year’s Honour’s List for services to diabetes research.



Roberta Lamptey, Family Physician Diabetologist Korle Bu Teaching HospitalRoberta Lamptey MBChB, FWACP,FGCP, PGDip, MSc, PhD

Consultant Family Physician and Diabetologist, Korle Bu Teaching Hospital, Ghana

Dr. Roberta Lamptey is a consultant Family Physician for the Korle Bu Teaching Hospital (KBTH) in Accra, Ghana, with over a decade of experience. She also serves as a diabetes expert for the Ghana Health Service. Roberta is passionate about self-management education and support. Her research is focused on self-management of diabetes and improving care outcomes at the primary care level. She is a co-PI in an on-going study on improving outcomes of cardio-metabolic diseases in Ghana, Kenya, and Mozambique. She has authored national guidelines and publications in high-impact journals including The Lancet.


Nisa Maruthur, MD at Johns Hopkins UniversityNisa Maruthur MD, MHS

Associate Professor of Medicine, Epidemiology, & Nursing, Johns Hopkins University, USA

Dr. Nisa Maruthur is Associate Professor of Medicine, Epidemiology and Nursing at Johns Hopkins University.  She is the Co-Medical Director for the Baltimore Metropolitan Diabetes Regional Partnership at Johns Hopkins, which coordinates the Diabetes Prevention Programs and Diabetes Self-Managements Training in our region.   She is also the Director of Community Program Implementation for the Brancati Center for the Advancement of Community Care; in this role, she leads community-based Diabetes Prevention Programs in Baltimore.  Dr. Maruthur completed her medical degree at Northwestern University Feinberg School of Medicine and her residency and fellowship training at Johns Hopkins. Dr. Maruthur served on the consensus panel of the EASD/ADA on the Management of Hyperglycemia in Type 2 diabetes in 2021-2022. She is a general internist with an active primary care practice and conducts research on diabetes prevention and the individualized care of diabetes.


Claire Meek, PhD, University of Cambridge UKClaire Meek, PhD, BM ChB

Senior Clinical Research Associate, Institute of Metabolic Science, University of Cambridge, UK Consultant; Physician, Diabetes in Pregnancy Service, Addenbrooke’s Hospital, Cambridge

Dr. Claire Meek is a clinical consultant in diabetes in pregnancy at Addenbrooke’s hospital, Cambridge (UK) and a principal investigator at the Institute of Metabolic Science, University of Cambridge. She is supported by a Diabetes UK intermediate clinical fellowship and Future Leaders’ Award from the European Foundation for the Study of Diabetes in association with the Novo Nordisk Foundation. She has also won several national and international awards including the Young Investigator Award and Pregnancy special interest group award from the American Diabetes Association, the Young Investigator Award from the Association of Physicians (UK) and the British Medical Foundation Helen H Lawson Award. Dr. Meek runs a research team which includes scientists and healthcare professionals who work together to run interventional and observational clinical studies in diabetes, nutrition and obesity in pregnancy.


Athena Philips-Tsimikas, MD at Scripps Whittier Diabetes InstituteAthena Philis-Tsimikas, MD
Corporate Vice President of the Scripps Whittier Diabetes Institute at Scripps Health, USA

Board-certified endocrinologist Dr. Athena Philis-Tsimikas is the Corporate Vice President of the Scripps Whittier Diabetes Institute at Scripps Health and the Director of Community Engagement for the Clinical Translational Science Award, housed at Scripps Research Translational Institute in San Diego, California. With over 25 years of experience, she has served as a member of the Scripps Clinic Medical Group in the Division of Endocrinology and Diabetes and leads the Diabetes Care Line for Scripps Health, which creates programs, conducts research, and delivers diabetes services across five Scripps hospitals, twenty five outpatient facilities, and the community. She is a leader of the innovative Project Dulce and Dulce Digital program, which cares for underserved populations with diabetes. Dr. Philis-Tsimikas and Scripps Whittier Diabetes Institute are actively promoting the participation of health centers in community-based clinical research with a focus on integrating digital technologies to improve diabetes care in the ambulatory and hospital setting. 


Tsvetalina Tankova, MD, PhD, DMedSc Head of Department of Diabetology, Chair in Endocrinology, Medical University-Sofia, BulgariaTsvetalina Tankova, MD, PhD, DMedSc
Head of Department of Diabetology, Chair in Endocrinology, Medical University-Sofia, Bulgaria

Professor Tankova is Chair in Endocrinology and Vice Rector at Medical University-Sofia, Bulgaria and the Head of Department of Diabetology at University Hospital of Endocrinology, Sofia. She graduated from the Medical University, Sofia, where she obtained PhD and DMedSc degrees, and specialist degrees in internal medicine and endocrinology as well as a Master’s degree in public health and healthcare management. Professor Tankova has also trained at the World Health Organization (WHO) Collaborating Center; University Hospital, Geneva, Switzerland; King's College Hospital, London, UK; and Steno Diabetes Center, Copenhagen, Denmark.  With over 260 publications in peer-reviewed journals, she also co-author the ADA/EASD Consensus Report on the management of hyperglycemia in type 2 diabetes in 2022. She has given 460 presentations at scientific events and has been an Invited speaker at EASD postgraduate training courses in many countries and is a member of the Guidelines Oversight Committee at EASD. In addition, she is Chair of the Expert Council on Endocrinology at Bulgarian Ministry of Health; Secretary of Bulgarian Society of Endocrinology since 2003. Her research interests in diabetes, prediabetes, diabetes complications, obesity, metabolic syndrome.


See Information on Past Solvable Problems in Diabetes Events:

Solvable Problems at ATTD 2023

Solvable Problems at EASD 2022

Solvable Problems at EASD 2021

Thanks to our sponsors for making this event possible

Platinum Sponsor

Novo Nordisk logo

Gold Sponsors

Abbott Laboratories logoDexcom LogoEli Lilly logoSanofi logo

Bronze Sponsors

Boehringer-Ingleheim logoEmbecta logo


Prosciento logo


Vertex Pharmaceuticals logo